STOCK TITAN

AmBase Corporation (ABCP) adds $1M CEO funding for litigation

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

AmBase Corporation entered into a new letter agreement with its Chairman, President and Chief Executive Officer, Richard A. Bianco, under which Bianco provided an additional $1,000,000 on July 30, 2026. This funding, made on the same terms as the existing 2026 Litigation Funding Agreement that permits up to an initial $6,000,000, is intended for working capital and ongoing legal costs related to the 111 West 57th Property.

The company notes that its financial statements contain a going‑concern qualification and that it must raise further capital to fund operations and litigation. Management is evaluating strategic alternatives, including additional equity or debt, borrowings from affiliates or others, and further litigation funding arrangements, but there is no assurance of securing financing or recovering the value of its investment in the 111 West 57th Property.

Positive

  • Chairman and CEO Richard A. Bianco has provided an additional $1,000,000 under existing funding arrangements, supporting AmBase’s working capital and litigation efforts related to the 111 West 57th Property.

Negative

  • AmBase continues to face a going‑concern qualification and must raise additional capital to fund operations and litigation; failure to recover value from the 111 West 57th Property would likely have a material adverse effect on its financial condition.

Filing Explained

The received litigation funding may require priority repayment and added charges, leaving its effect on recovery economics unresolved.

This Form 8-K reports a material agreement: on July 30, 2026, Richard A. Bianco paid $1 million to AmBase Corporation under the existing litigation funding arrangement. The payment is completed and is designated for working capital and continuing litigation expenses, adding funding while the company says it still needs additional capital and reports a going-concern qualification.

The company describes litigation funding agreements generally as requiring the funder to receive its initial funding back first, followed by an additional multiple of 1.0 to 3.5 times the funded amount, with possible fees, expenses, interest, and a share of recovery. Because this filing does not specify the exact multiple or other charges applicable to this payment, its ultimate cost and effect on any litigation recovery cannot be sized from this disclosure.

At March 31, 2026, the company reported $533,000 of cash and equivalents and $1.454 million of quarterly operating cash outflow; that historical cash position equals 33 days of the last reported operating cash use.

The material watch items are a later filing specifying the funding agreement’s repayment, multiple, fee, interest, or recovery-share terms and any disclosure that additional capital has been obtained.

Sources and calculations
  • AmBase Corporation Form 8-K (2026-07-31)
  • Form 8-K purpose (current)
  • Going-concern qualification (current)
  • AmBase Corporation 2026 first-quarter fundamentals (2026-03-31)
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $533,000 / ($1,454,000 / 90) = [object Object]
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Litigation funding agreement capacity $6,000,000 Aggregate initial amount available under the RAB 2026 Litigation Funding Agreement with Richard A. Bianco
Additional CEO funding July 30, 2026 $1,000,000 Paid by Richard A. Bianco for working capital and litigation expenses related to the 111 West 57th Property
Litigation funding return multiple 1.0 times to 3.5 times Typical multiple of the funded amount litigation funders may receive before AmBase receives any recovery
Litigation Funding Agreement financial
"entered into a Litigation Funding Agreement (the “RAB 2026 LFA”)"
going concern financial
"financial statements have expressed a qualification about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
strategic alternatives financial
"continues to explore all possible strategic alternatives to meet its capital needs"
Strategic alternatives are different options a company considers to improve its value or achieve its goals, such as selling the business, merging with another company, or restructuring operations. For investors, understanding these options is important because they can significantly impact the company's future direction and its stock value, often signaling potential changes or opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What new funding did AmBase Corporation (ABCP) receive from its CEO?

AmBase received an additional $1,000,000 from Chairman and CEO Richard A. Bianco on July 30, 2026. The money is for working capital and ongoing litigation expenses tied to the 111 West 57th Property, under the same terms as the existing 2026 funding agreement.

How much total funding can AmBase (ABCP) access under the RAB 2026 Litigation Funding Agreement?

The RAB 2026 Litigation Funding Agreement allows Chairman and CEO Richard A. Bianco to provide up to an aggregate initial amount of $6,000,000. The July 30, 2026 $1,000,000 payment is additional funding made on the same terms as that agreement.

What is the purpose of the new $1,000,000 funding for AmBase (ABCP)?

The additional $1,000,000 is designated for AmBase’s working capital needs and continuing litigation-related expenses. These costs are specifically associated with the company’s disputes regarding its equity investment in the 111 West 57th Property.

What financial risks does AmBase (ABCP) highlight regarding its ability to continue operating?

AmBase states that its financial statements carry a going‑concern qualification and it must raise more capital. Management is exploring equity, debt, affiliate borrowings, and litigation funding, but there is no assurance of obtaining financing or recovering its investment value.

How do typical litigation funding agreements affect AmBase’s potential recoveries?

The company notes that litigation funders generally receive their funded amount back first, plus a multiple of about 1.0 to 3.5 times, and possibly added fees, expenses, interest, and a percentage of total recovery, which reduces what AmBase might ultimately retain.

What strategic options is AmBase (ABCP) considering for the 111 West 57th Property?

AmBase is pursuing legal actions and other options to realize value from the 111 West 57th Property, including potential sale of its interest or rights. It cautions there is no assurance it will prevail in its claims or recover its investment.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
Current Report
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 31, 2026 (July 30, 2026)
 
AMBASE CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
1-07265
95-2962743
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification Number)
 
7857 WEST SAMPLE ROAD, SUITE 134
CORAL SPRINGS, FLORIDA 33065
(Address of principal executive offices, including zip code)
 
(201) 265-0169
(Registrant's telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
 
None.
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

1

 
Item 1.01
Entry Into a Material Definitive Agreement.
 
On March 2, 2026, AmBase Corporation, a Delaware corporation (“AmBase” or the “Company”) and Mr. Richard A. Bianco, the Company’s Chairman, President and Chief Executive Officer (“RAB”) entered into a Litigation Funding Agreement (the “RAB 2026 LFA”), pursuant to which the Company and RAB agreed that RAB will provide up to an aggregate initial amount of Six Million Dollars ($6,000,000) (plus such additional amounts as may be necessary from time to time and as agreed to by the Company and RAB at such time), as further described in the Company’s Current Report on Form 8-K as filed with the SEC on March 4, 2026, and incorporated herein by reference. On July 30, 2026, the Company and RAB entered into a letter agreement (the “Letter Agreement”) pursuant to which RAB paid the Company an additional $1,000,000, for use by the Company for working capital needs and continuing litigation related expenses with respect to the 111 West 57th Property. The additional amounts contributed by RAB were made pursuant to the same terms and conditions of the RAB 2026 LFA. A copy of the Letter Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
As previously disclosed in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s financial statements have expressed a qualification about the Company’s ability to continue as a going concern.
 
In order to continue as a going concern and fund anticipated future litigation expenses, the Company will need to raise additional capital. The Company continues to explore all possible strategic alternatives to meet is capital needs, including but not limited to, raising additional capital through the sale of equity or debt securities or long-term borrowings, which may include additional borrowings from affiliates of the Company, financial institutions or other stockholders of the Company, litigation funding agreements from affiliates of the Company, financial institutions, other stockholders of the Company, or other third parties, and seeking recoveries from various sources. The Company intends for any sales of debt or equity securities or any borrowings from any parties to be on market terms to be agreed upon at the time of any transaction. However, there can be no assurance that the Company will be able to raise capital or obtain financing on terms acceptable to the Company, if at all.
 
As noted above, the Company continues to explore all possible strategic alternatives to meet its capital needs. Litigation funding agreements are special types of financing arrangements that generally are structured so that the litigation funder would receive back their initial funding amount first (i.e. before any recovery is received by the Company), plus an additional multiple ranging from 1.0 times to 3.5 times the amount funded (depending on various factors), plus depending on the funder, additional fees, expenses, interest and potentially an additional percentage of the total recovery received. If the Company continues to source capital through one or more litigation funding agreements, there can be no assurance that the Company would be able to secure any such additional litigation funding on acceptable terms or at all.
 
While the Company’s management is evaluating future courses of action to protect and/or recover the value of the Company’s equity investment in the 111 West 57th Property, the adverse developments make it uncertain as to whether any such courses of action will be successful. Any such efforts are likely to require sustained effort over a period of time and substantial additional capital. The Company continues to explore all possible strategic alternatives to meet is capital needs, including but not limited to, raising additional capital through the sale of equity or debt securities or long-term borrowings, which may include additional borrowings from affiliates of the Company, financial institutions or other stockholders of the Company, litigation funding agreements from affiliates of the Company, financial institutions, other stockholders of the Company, or other third parties, and seeking recoveries from various sources. Inability to recover all or most of such value would, in all likelihood, have a material adverse effect on the Company’s financial condition and future prospects. The Company can give no assurances with regard if it will prevail with respect to any of its claims.
 
With respect to its disputes and litigation relating to its interest in the 111 West 57th Property, the Company is pursuing, and will continue to pursue, other options to realize the Company’s investment value, various legal courses of action to protect its legal rights, recovery of its asset value from various sources of recovery, as well as considering other possible economic strategies, including the possible sale of the Company’s interest in and/or rights with respect to the 111 West 57th Property; however, there can be no assurance that the Company will prevail with respect to any of its claims.
 
The information in this Current Report on Form 8-K should be read in conjunction with the Company’s annual report on Form 10-K for the year ended December 31, 2025, and the Company’s reports filed with the SEC (collectively, the “Prior Periodic Reports”). A more complete discussion of the Company's financial condition and results of operations are also set forth in the Prior Periodic Reports, including without limitation the disclosures under the headings “Risk Factors” and “Cautionary Statement for Forward-Looking Information.”
 
2

 
Item 9.01
Financial Statements and Exhibits
 
(d) Exhibits
 
   
Exhibit Number
  Exhibit Title
     
10.1   Letter Agreement between AmBase Corporation and Richard A. Bianco dated July 30, 2026.  
     
104.1   The Cover Page from this Current Report on Form 8-K, formatted in Inline XBRL.
 
3

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
       
 
AMBASE CORPORATION
 
 
 
By
/s/ John Ferrara
 
 
John Ferrara
 
Vice President and Chief Financial Officer and Controller
 
AmBase Corporation
 
Date: July 31, 2026
 
 

FL 0000020639 false 0000020639 2026-07-30 2026-07-30

Filing Exhibits & Attachments

4 documents